NCT05253339View on ClinicalTrials.gov

The Expected Advantage of Administering Prophylactic Antibiotics Using Target- Concentration Controlled Infusion

NACompletedINTERVENTIONAL
Enrollment

2,494

Participants

Timeline

Start Date

April 4, 2022

Primary Completion Date

August 28, 2025

Study Completion Date

August 28, 2025

Conditions
Anti-bacterial AgentsPharmacokineticsGeneral Surgery
Interventions
PROCEDURE

target-controlled infusion (one of the administration methods)

a method of administering cefoxitin while maintaining a constant target concentration.

PROCEDURE

Standard administration method

Standard method of administering cefoxitin in the current clinical setting

Trial Locations (1)

05505

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Seoul Business Agency

UNKNOWN

lead

Asan Medical Center

OTHER

NCT05253339 - The Expected Advantage of Administering Prophylactic Antibiotics Using Target- Concentration Controlled Infusion | Biotech Hunter | Biotech Hunter